Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

BackgroundAcromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing efforts to develop new drugs with improved effectiveness for this disease. BIM2...

Full description

Bibliographic Details
Main Authors: Jean Kim, Ju Hun Oh, Heather Harlem, Michael D. Culler, Cheol Ryong Ku, Eun Jig Lee
Format: Article
Language:English
Published: Academya Publishing Co. 2020-03-01
Series:Endocrinology and Metabolism
Subjects:
acromegaly
therapeutics
growth hormone
insulin-like growth factor i
pituitary neoplasms
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-35-177.pdf

Internet

https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-35-177.pdf

Similar Items